{"version":"1.0","type":"link","title":"Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial.","author_name":"Karimi YH 외","author_url":"https://prs-insight.online/author/Karimi%20YH","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/162095","thumbnail_width":1200,"thumbnail_height":630}